CD4 regulatory T cells in human cancer pathogenesis - PubMed (original) (raw)

Review

CD4 regulatory T cells in human cancer pathogenesis

Keith L Knutson et al. Cancer Immunol Immunother. 2007 Mar.

Abstract

Over the past decade, there has been an accelerated understanding of immune regulatory mechanisms. Peripheral immune regulation is linked to a collection of specialized regulatory cells of the CD4(+) T cell lineage (i.e., CD4(+) Tregs). This collection consists of Tregs that are either thymically derived (i.e., natural) or peripherally induced. Tregs are important for controlling potentially autoreactive immune effectors and immunity to foreign organisms and molecules. Their importance in maintaining immune homeostasis and the overall health of an organism is clear. However, Tregs may also be involved in the pathogenesis of malignancies as now compelling evidence shows that tumors induce or recruit CD4(+) Tregs to block immune priming and antitumor effectors. Efforts are underway to develop approaches that specifically inhibit the function of tumor-associated Tregs which could lead to an increased capability of the body's immune system to respond to tumors but without off-target immune-related pathologies (i.e., autoimmune disease). In this review, the biology of human CD4(+) Tregs is discussed along with their involvement in malignancies and emerging strategies to block their function.

PubMed Disclaimer

Similar articles

• Strong-arming immune regulation: suppressing regulatory T-cell function to treat cancers.
  Knutson KL. Knutson KL. Future Oncol. 2006 Jun;2(3):379-89. doi: 10.2217/14796694.2.3.379. Future Oncol. 2006. PMID: 16787118 Review.
• Targeting regulatory T cells for anticancer therapy.
  D'Arena G, Deaglio S, Laurenti L, De Martino L, De Feo V, Fusco BM, Carella AM, Cascavilla N, Musto P. D'Arena G, et al. Mini Rev Med Chem. 2011 Jun;11(6):480-5. doi: 10.2174/138955711795843365. Mini Rev Med Chem. 2011. PMID: 21561409
• CD4+CD25+ regulatory T cells in tumor immunity.
  Chen X, Du Y, Lin X, Qian Y, Zhou T, Huang Z. Chen X, et al. Int Immunopharmacol. 2016 May;34:244-249. doi: 10.1016/j.intimp.2016.03.009. Epub 2016 Mar 16. Int Immunopharmacol. 2016. PMID: 26994448 Review.
• CD4+ T-regulatory cells: toward therapy for human diseases.
  Allan SE, Broady R, Gregori S, Himmel ME, Locke N, Roncarolo MG, Bacchetta R, Levings MK. Allan SE, et al. Immunol Rev. 2008 Jun;223:391-421. doi: 10.1111/j.1600-065X.2008.00634.x. Immunol Rev. 2008. PMID: 18613849 Review.
• Regulatory T cells in cancer.
  Mougiakakos D, Choudhury A, Lladser A, Kiessling R, Johansson CC. Mougiakakos D, et al. Adv Cancer Res. 2010;107:57-117. doi: 10.1016/S0065-230X(10)07003-X. Adv Cancer Res. 2010. PMID: 20399961 Review.

Cited by

• Tumour cell generation of inducible regulatory T-cells in multiple myeloma is contact-dependent and antigen-presenting cell-independent.
  Feyler S, Scott GB, Parrish C, Jarmin S, Evans P, Short M, McKinley K, Selby PJ, Cook G. Feyler S, et al. PLoS One. 2012;7(5):e35981. doi: 10.1371/journal.pone.0035981. Epub 2012 May 29. PLoS One. 2012. PMID: 22666318 Free PMC article.
• T cells in gastric cancer: friends or foes.
  Amedei A, Della Bella C, Silvestri E, Prisco D, D'Elios MM. Amedei A, et al. Clin Dev Immunol. 2012;2012:690571. doi: 10.1155/2012/690571. Epub 2012 May 31. Clin Dev Immunol. 2012. PMID: 22693525 Free PMC article. Review.
• CD4+ T-cell recognition of human 5T4 oncofoetal antigen: implications for initial depletion of CD25+ T cells.
  Elkord E, Burt DJ, Drijfhout JW, Hawkins RE, Stern PL. Elkord E, et al. Cancer Immunol Immunother. 2008 Jun;57(6):833-47. doi: 10.1007/s00262-007-0419-8. Epub 2007 Nov 15. Cancer Immunol Immunother. 2008. PMID: 18004564 Free PMC article.
• The role of tregs in glioma-mediated immunosuppression: potential target for intervention.
  Humphries W, Wei J, Sampson JH, Heimberger AB. Humphries W, et al. Neurosurg Clin N Am. 2010 Jan;21(1):125-37. doi: 10.1016/j.nec.2009.08.012. Neurosurg Clin N Am. 2010. PMID: 19944972 Free PMC article. Review.
• Correlation and prognostic implications of intratumor and tumor draining lymph node Foxp3+ T regulatory cells in colorectal cancer.
  Yan B, Xiong J, Ye Q, Xue T, Xiang J, Xu M, Li F, Wen W. Yan B, et al. BMC Gastroenterol. 2022 Mar 16;22(1):122. doi: 10.1186/s12876-022-02205-0. BMC Gastroenterol. 2022. PMID: 35296257 Free PMC article.

References

1. 1. Hogquist KA, Baldwin TA, Jameson SC. Central tolerance: learning self-control in the thymus. Nat Rev Immunol. 2005;5:772–782. - PubMed
2. 1. Buckner JH, Ziegler SF. Regulating the immune system: the induction of regulatory T cells in the periphery. Arthritis Res Ther. 2004;6:215–222. - PMC - PubMed
3. 1. Redmond WL, Sherman LA. Peripheral tolerance of CD8 T lymphocytes. Immunity. 2005;22:275–284. - PubMed
4. 1. Kronenberg M, Rudensky A. Regulation of immunity by self-reactive T cells. Nature. 2005;435:598–604. - PubMed
5. 1. Mills KH, McGuirk P. Antigen-specific regulatory T cells—their induction and role in infection. Semin Immunol. 2004;16:107–117. - PubMed

Publication types

MeSH terms

LinkOut - more resources

• Full Text Sources

  • Europe PubMed Central
  • PubMed Central
  • Springer

• Other Literature Sources

  • The Lens - Patent Citations Database

• Research Materials

  • NCI CPTC Antibody Characterization Program

• Miscellaneous

  • NCI CPTAC Assay Portal